09: Genome Editing: Regulierung an der Grenze zur Ungewissheit
In Zusammenarbeit mit Woodrow Wilson International Center for Scholars
-
Hauptschule
Breakout
/
in englischer SpracheUnsere Erfindungen verändern die Welt und die neu erfundene Welt verändert uns. Hinter Konflikten und Kooperationen liegt die Frage der Risikoverantwortung. Wessen Pflicht ist es in den heutigen komplexen Gesellschaften, die negativen Auswirkungen von störenden Technologien wie Gen-Editing vorauszusehen? Haben wir die notwendigen Werkzeuge und Instrumente zur Prognose und Vermeidung von Schäden?
| |||||
| |||||
| |||||
| |||||
|
Thomas LANDRAIN
Co-Founder and President, Just One Giant Lab; Co-Founder and ex Chief Executive Officer, PILI and La Paillasse, Paris
| 2002-2005 | Licence (B.Sc.), Molecular Biology and Physiology, Institut catholique d’etudes superieures |
| 2005-2007 | Master, Biology - Genetics, Universite Paris Diderot |
| Master, Biology - Genetics, ENS - Ecole normale superieure | |
| 2007-2008 | Master, Interdisciplinary Approach to Life Sciences, Universite Denis Diderot (Paris VII) |
| 2009-2014 | Doctor of Philosophy - PhD, Synthetic Biology, Universite Paris-Saclay |
| since 2014 | Mentor, IndieBio |
| since 2017 | Member of the Digital Strategy Board, APHP, Paris |
| Co-Founder and Board Member, La Paillasse, Paris | |
| Co-Founder and President, Just One Giant Lab, Paris |
Dr. Jenny MOLLOY
Coordinator, OpenPlant & SynBio SRI, University of Cambridge
| 2010-2015 | DPhil Zoology, University of Oxford |
| since 2015 | Coordinator, OpenPlant and Synthetic Biology Strategic Research Initiative, University of Cambridge |
| since 2016 | Director, ContentMine Ltd. |
| Director, Biomakespace Ltd., Cambridge |
PhD Lalitha SUNDARAM
Post-Doctoral Research Associate, CSER - Centre for the Study of Existential Risk, University of Cambridge
| 2012-2014 | Senior Laboratory Technician, Department of Pathology, University of Cambridge |
| 2014-2016 | Research Associate, Arsenic Biosensor Collaboration, Department of Pathology, University of Cambridge |
| 2016-2017 | Post-Doctoral Research Fellow, Emerging Biotechnologies and Global Health, Department of Global Health and Social Medicine, King's College London |
| 2017 | PhD, Department of Pathology, University of Cambridge; PhD Viva: Provisional Pass, subject to corrections |
| since 2017 | Post-Doctoral Research Associate, Bio-Risk, Centre for the Studiy of Existential Risk, University of Cambridge |
Rüdiger TROJOK
Scientific Staff, ITAS - Institute for Technology Assessment and Systems Analysis, KIT - Karlsruhe Institute for Technology, Berlin
Eleonore PAUWELS
Senior Program Associate, Director of Biology Collectives Project, Woodrow Wilson International Center for Scholars, Washington, D.C.
| 2005-2006 | United Nation Development Program (UNDP), Democratic Governance Group, Brussels |
| 2006-2008 | European Commission, Directorate-General for Research, Unit Governance and Ethics— Ethics Review/National Experts, Brussels |
| 2008-2013 | Woodrow Wilson International Center for Scholars, Science and Technology Innovation Program (STIP) - Public Policy Scholar, Washington, D.C. |
| since 2013 | Woodrow Wilson International Center for Scholars, Science and Technology Innovation Program (STIP) - Director of Biology Collectives, Washington, D.C. |
| Co-PI, SYNENERGENE (321488, FP7), EU Project on Responsible Innovation in Genomics | |
| since 2017 | IEEE Committee Member on Artificial Intelligence |
| Research Associate with the AI Initiative, The Future Society, Harvard Kennedy School, Cambridge, MA |
